Literature DB >> 11606322

Mechanism of trypsin-induced endothelium-dependent vasorelaxation in the porcine coronary artery.

T Nakayama1, K Hirano, J Nishimura, S Takahashi, H Kanaide.   

Abstract

1. To investigate the mechanism underlying the trypsin-induced endothelium-dependent relaxation, cytosolic Ca(2+) concentration ([Ca(2+)](i)) and tension development of smooth muscle were simultaneously monitored in the porcine coronary artery, and [Ca(2+)](i) of in situ endothelial cells were monitored in the porcine aortic valvular strips, using fura-2 fluorometry. 2. During the contraction induced by 30 nM U46619, a thromboxane A(2) analogue, 100 nM trypsin induced a rapid transient significant decrease in both [Ca(2+)](i) (from 67.9+/-5.1 to 15.7+/-4.4%) and tension (from 97.5+/-9.2 to 16.8+/-3.5%) of smooth muscle only in the presence of endothelium (100% level was assigned to the level obtained with the 118 mM K(+)-induced contraction). [Ca(2+)](i) and the tension thus returned to the levels prior to the application of trypsin by 5 and 10 min, respectively. 3. The initial phase of this relaxation was partly inhibited by 100 microM N(omega)-nitro-L-arginine (L-NOARG), and was completely inhibited by L-NOARG plus 40 mM K(+) or L-NOARG plus 100 nM charybdotoxin and 100 nM apamin, while the late phase of the relaxation was inhibited by L-NOARG alone. 4. Trypsin induced a transient [Ca(2+)](i) elevation in the endothelial cells mainly due to the Ca(2+) release from the intracellular stores, at the concentrations (1 - 100 nM) similar to those required to induce relaxation. 5. In conclusion, trypsin induced an elevation in [Ca(2+)](i) mainly due to Ca(2+) release in endothelial cells, and thereby caused endothelium-dependent relaxation. The early phase of relaxation was due to nitric oxide and hyperpolarizing factors, while the late phase was mainly due to nitric oxide in the porcine coronary artery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606322      PMCID: PMC1573010          DOI: 10.1038/sj.bjp.0704318

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Modulation by protease-activated receptors of the rat duodenal motility in vitro: possible mechanisms underlying the evoked contraction and relaxation.

Authors:  A Kawabata; R Kuroda; H Nishikawa; K Kawai
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

2.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Authors:  L J Ignarro; G M Buga; K S Wood; R E Byrns; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Organic-anion transport inhibitors to facilitate measurement of cytosolic free Ca2+ with fura-2.

Authors:  F Di Virgilio; T H Steinberg; S C Silverstein
Journal:  Methods Cell Biol       Date:  1989       Impact factor: 1.441

4.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

5.  Radioimmunoassay of human plasma trypsin.

Authors:  R S Temler; J P Felber
Journal:  Biochim Biophys Acta       Date:  1976-10-11

6.  Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo.

Authors:  C Cicala; A Pinto; M Bucci; R Sorrentino; B Walker; P Harriot; A Cruchley; S Kapas; G L Howells; G Cirino
Journal:  Circulation       Date:  1999-05-18       Impact factor: 29.690

7.  Heterogeneous mechanisms of endothelium-dependent relaxation for thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary artery.

Authors:  J R Hamilton; T M Cocks
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

8.  Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease-activated receptor-2 activation.

Authors:  C G Sobey; J D Moffatt; T M Cocks
Journal:  Stroke       Date:  1999-09       Impact factor: 7.914

9.  A dual thrombin receptor system for platelet activation.

Authors:  M L Kahn; Y W Zheng; W Huang; V Bigornia; D Zeng; S Moff; R V Farese; C Tam; S R Coughlin
Journal:  Nature       Date:  1998-08-13       Impact factor: 49.962

10.  Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein: release of a contracting factor via a novel receptor.

Authors:  M Saifeddine; S S Roy; B Al-Ani; C R Triggle; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1998-12       Impact factor: 8.739

View more
  5 in total

1.  Proteinase-activated receptor 2 activation modulates guinea-pig mesenteric lymphatic vessel pacemaker potential and contractile activity.

Authors:  Alice K Chan; Nathalie Vergnolle; Morley D Hollenberg; Pierre-Yves von der Weid
Journal:  J Physiol       Date:  2004-08-26       Impact factor: 5.182

2.  Protease activated receptors in cardiovascular function and disease.

Authors:  Junor A Barnes; Shamjeet Singh; Aldrin V Gomes
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

3.  Protease-activated receptor-2 augments experimental crescentic glomerulonephritis.

Authors:  Leon Moussa; Jim Apostolopoulos; Piers Davenport; Jorge Tchongue; Peter G Tipping
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

4.  Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells.

Authors:  Tetsuzo Nakayama; Katsuya Hirano; Yoshinobu Shintani; Junji Nishimura; Akio Nakatsuka; Hirotaka Kuga; Shosuke Takahashi; Hideo Kanaide
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 5.  Influenza virus pathogenicity regulated by host cellular proteases, cytokines and metabolites, and its therapeutic options.

Authors:  Hiroshi Kido
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2015       Impact factor: 3.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.